Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma

  • Authors:
    • Susumu Matsukuma
    • Oh Takahashi
    • Yoshitaka Utsumi
    • Masaki Tsuda
    • Kosuke Miyai
    • Kenji Okada
    • Hiroaki Takeo
  • View Affiliations

  • Published online on: August 23, 2017     https://doi.org/10.3892/ol.2017.6804
  • Pages: 4918-4922
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Herein is described a unique case of esophageal cancer mimicking acantholytic squamous cell carcinoma (SCC). The patient succumbed to the disease within one month of diagnosis. Autopsy revealed a 10‑cm esophageal tumor, characterized by prominent acantholysis‑like areas composed of discohesive cancer cells, along with nested growth of SCC. These discohesive cancer cells focally exhibited pagetoid extension into adjacent esophageal epithelium, comprised ~60% of the esophageal tumor volume and had widely metastasized to the lungs, chest wall, liver, spleen, right adrenal gland, bones and lymph nodes. No metastases of SCC were observed. SCC cells were immunohistochemically positive for keratin 5/6 and E‑cadherin and were negative for mucin and carcinoembryonic antigen (CEA). However, the discohesive cancer cells exhibited negativity for keratin 5/6, positivity for mucin and CEA, and diminished or no immunostaining for E‑cadherin. Thus, these discohesive cells represented true adenocarcinomatous differentiation rather than acantholytic SCC cells. It was concluded that this tumor was an esophageal adenosquamous carcinoma with ‘pseudo’‑acantholytic adenocarcinoma components, which should be considered as a rare but distinctive type of aggressive cancer.

Introduction

Squamous cell carcinoma (SCC) is the most common type of esophageal cancer, followed by adenocarcinoma; these two histological types account for >90% of primary esophageal cancer cases (15). Adenocarcinoma arises chiefly in Barrett mucosa and rarely from ectopic gastric mucosa or esophageal glands (2). However, focal adenocarcinomatous differentiation occurs in ~20% of cases of esophageal invasive SCC (1,6). When the adenocarcinomatous features occupy considerable amounts of the esophageal SCC, tumors are classified as either adenosquamous carcinoma or mucoepidermoid carcinoma (1,2,711). Adenocarcinomatous differentiation in SCC should be distinguished from acantholytic SCC (also called pseudoglandular or adenoid SCC) (1219). Here was encountered a unique autopsy case of esophageal adenosquamous carcinoma mimicking acantholytic SCC, and herein is describe the clinicopathological findings of this case.

Case report

A 53-year-old Japanese male was hospitalized firstly to Japan Self-Defense Force Hanshin Hospital (Hyogo, Japan) on April 1, 2011, and subsequently to Japan Self-Defense Forces Central Hospital (Tokyo, Japan) on April 14, 2011, for evaluation of fever and hoarseness. Laboratory examination revealed increased serum levels of C-reactive protein and carcinoembryonic antigen (CEA). Endoscopic examination disclosed an ulcerating esophageal tumor. The biopsy specimen exhibited features of moderate-poorly differentiated SCC. A computed tomography scan confirmed the presence of an esophageal tumor and revealed possible metastatic nodules in the liver and mediastinal and intra-abdominal lymph nodes (Fig. 1). The fever and hoarseness were considered to be caused by tumor necrosis and lymph node metastasis-associated recurrent nerve palsy, respectively. The patient rapidly deteriorated and succumbed to respiratory insufficiency one month following first hospitalization.

Autopsy revealed a 10-cm ulcerating esophageal tumor (Fig. 2A) directly invading the trachea. Microscopically, this tumor partially exhibited nested proliferation composed of polygonal and/or short spindle cells containing swollen pleomorphic nuclei without distinct keratinization (Fig. 2B). These features indicate a diagnosis of poor-moderately differentiated SCC. However, invading cancerous nests frequently exhibited geographic acantholysis-like changes (Fig. 2C), chiefly composed of poorly cohesive, monomorphic neoplastic cells with relatively scant cytoplasm. These acantholytic areas were slightly demarcated, occasionally contained necrotic cells (Fig. 2D), and lacked columnar cells, intermediate cells and neoplastic cells forming tubules or intracytoplasmic lumina. These discohesive cancer cells also invaded in an alveolar fashion (Fig. 2E), reminiscent of micropapillary carcinoma, and focally involved the adjacent esophageal epithelium in a pagetoid manner (Fig. 2F). In total, these discohesive cancer cells comprised ~60% of the tumor volume, and had widely metastasized to the lungs, chest wall, liver, spleen, right adrenal gland, vertebral bones and generalized lymph nodes with multifocal necrosis. Notably, in both lungs, metastatic discohesive cells exhibited prominent lymphangiosis (Fig. 2G), which would have contributed to the respiratory failure and causing the patient's mortality. Metastatic SCC cells were not observed.

In the primary esophageal tumor, SCC cells were negative for mucin staining and CEA and were weakly positive for keratin 5/6 (K5/6); scattered positivity for epithelial membrane antigen (EMA) in SCC cells was also observed. By contrast, discohesive cancer cells commonly expressed mucin, which was detected by alcian blue and/or periodic acid-Schiff (PAS) staining with or without diastase digestion (Fig. 3A and F). In addition, discohesive cancer cells exhibited strong positivity for EMA (Fig. 3B) and CEA (Fig. 3C), and negativity for K5/6 (Fig. 3D). In the primary tumor, SCC cells exhibited weak cytoplasmic positivity for E-cadherin. By contrast, discohesive cancer cells exhibited reduced or no E-cadherin immunostaining as compared with the weak staining of the surrounding cohesive cancer cells (Fig. 3E). In metastatic lesions, cancer cells exhibited occasional expression of mucin, and EMA positivity, CEA positivity and K5/6 negativity were observed via immunohistochemistry (Fig. 4). The majority of metastatic cancer cells exhibited negative or reduced E-cadherin immunostaining (Fig. 4C), although a minority of metastatic cancer cells were positive for E-cadherin. No positivity for p63, α-fetoprotein, placental alkaline phosphatase or vimentin was observed in any of the primary or metastatic cancerous lesions.

Discussion

The present esophageal tumor exhibited not only nested growth of SCC, but also frequent, loosely arranged acantholysis-like areas, which occasionally contained necrotic cells and lacked columnar cells and neoplastic tubules. These features closely mimicked acantholytic SCC, which is an uncommon but distinctive variant of SCC with dyskeratosis-associated acantholytic changes (3,1318). However, in the present acantholysis-like areas, the discohesive cancer cells exhibited alcian blue+ and/or PAS+ mucin, and were strongly positive for EMA and CEA. No K5/6 positivity was observed in these discohesive cells; however, K5/6 positivity was scattered in the SCC components and cohesive cells around the acantholysis-areas. These findings indicate that these acantholysis-like areas represent true adenocarcinomatous differentiation rather than acantholytic changes of SCC. The esophageal tumor involved both these adenocarcinoma (60%) and SCC (40%) cells, and lacked intermediate cells suggestive of mucoepidermoid carcinoma (1,2,7). Therefore, it was concluded that this tumor was esophageal adenosquamous carcinoma with ‘pseudo’-acantholytic adenocarcinoma components.

In the present case, the alveolar growth of the discohesive adenocarcinoma cells focally resembled those of micropapillary carcinoma in other sites (2022). However, the present alveolar cancer cells formed no distinctive micropapillary tufts or aggregations with a reversed polarity, eliminating a possible diagnosis of micropapillary carcinomatous components. Alveolar or prominently discohesive changes of adenocarcinoma cells have been rarely described in the lung (23), but these cases had no SCC components. Alwaheeb and Chetty (24) reported a case of acantholytic adenosquamous carcinoma of the pancreas. However, these acantholytic changes were observed in the SCC components, and not in the adenocarcinomatous components. Lee (19) described ‘signet ring cells’ in a case of esophageal acantholytic SCC, but these were negative for mucin and were considered to have arisen from vacuolar changes. The present review of the literature failed to reveal any cases of adenosquamous carcinoma with ‘pseudo’-acantholytic adenocarcinoma components in the esophagus or other sites.

Acantholytic changes of SCC are known to be associated with reduced E-cadherin immunoreactivity (14,15). In the present case, the discohesive adenocarcinoma cells exhibited diminished or negative staining for E-cadherin despite weak positivity in SCC cells. Furthermore, the discohesive adenocarcinoma cells aggressively metastasized to several organs, directly contributing to the patient's mortality, although SCC cells were not observed in the metastatic lesions. Furthermore, the majority of the metastatic cancer cells exhibited little or no E-cadherin staining. These findings suggest that the loss or alteration of E-cadherin in adenocarcinoma cells causes ‘pseudo’-acantholysis and also serves a role in aggressive metastasis (25). Notably, the adenocarcinoma cells in the present case focally involved the adjacent esophageal epithelium in a pagetoid manner, which is exceptionally rare in the esophagus (26,27). Abraham et al (27) also noted similar diminished E-cadherin immunostaining in esophageal Paget cells.

In conclusion, herein is described an autopsy case of esophageal adenosquamous carcinoma with ‘pseudo’-acantholytic adenocarcinoma components, possibly associated with the loss of E-cadherin. Therefore, this tumor should be considered as a rare but aggressive type of cancer in the differential diagnoses of esophageal neoplasms.

Glossary

Abbreviations

Abbreviations:

CEA

carcinoembryonic antigen

di-PAS

periodic acid-Schiff stain after diastase digestion

K5/6

keratin 5/6

EMA

epithelial membrane antigen

H&E

hematoxylin and eosin

SCC

squamous cell carcinoma

References

1 

Lewin KJ and Appelman HD: Tumors of the esophagus and stomach. In: Atlas of Tumor Pathology3rd. Fascicle 18. Rosai J and Sobin LH: American Registry of Pathology; Washington, DC: pp. 43–144. 1996

2 

Bosman FT, Carneiro F, Hruban RH and Theise ND: WHO Classification of Tumours of the Digestive System. 4th. International Agency for Research on Cancer; Lyon: pp. 18–31. 2010

3 

Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Brown LM, Devesa SS and Chow WH: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 100:1184–1187. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Yang CS, Chen X and Tu S: Etiology and prevention of esophageal cancer. Gastrointest Tumors. 3:3–16. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Takubo K, Sasajima K, Yamashita K, Tanaka Y, Fujita K, Mafune K and Wang QH: Morphological heterogeneity of esophageal carcinoma. Acta Pathol Jpn. 39:180–189. 1989.PubMed/NCBI

7 

Lam KY, Loke SL and Ma LT: Histochemistry of mucin secreting components in mucoepidermoid and adenosquamous carcinoma of the oesophagus. J Clin Pathol. 46:1011–1015. 1993. View Article : Google Scholar : PubMed/NCBI

8 

Bombí JA, Riverola A, Bordas JM and Cardesa A: Adenosquamous carcinoma of the esophagus. A case report. Pathol Res Pract. 187:514–521. 1991.PubMed/NCBI

9 

Yachida S, Nakanishi Y, Shimoda T, Nimura S, Igaki H, Tachimori Y and Kato H: Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology. 66:218–225. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Chen SB, Weng HR, Wang G, Yang JS, Yang WP, Liu DT, Chen YP and Zhang H: Primary adenosquamous carcinoma of the esophagus. World J Gastroenterol. 19:8382–8390. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Ni PZ, Yang YS, Hu WP, Wang WP, Yuan Y and Chen LQ: Primary adenosquamous carcinoma of the esophagus: An analysis of 39 cases. J Thorac Dis. 8:2689–2696. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Cardesa A, Zidar N and Alos L: Acantholytic squamous cell carcinoma. In: WHO Classification of TumoursPathology and Genetics of Head and Neck Tumours. Barnes L, Eveson JW, Reichart P and Sidransky D: IARC press; Lyon: pp. 1292005

13 

Elder DE, Elenitsas R, Rosenbach M, Murphy GF, Rubin AI and Xu X: Lever's Histopathology of the Skin. 11th. Wolters Kluwer; Philaderphia, PA: pp. 10032015

14 

Zidar N, Gale N, Župevc A and Dovšak D: Pseudovascular adenoid squamous-cell carcinoma of the oral cavity-a report of two cases. J Clin Pathol. 59:1206–1208. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Gu X, Jiang R and Fowler MR: Acantholytic squamous cell carcinoma in upper aerodigestive tract: Histopathology, immunohistochemical profile and epithelial mesenchymal transition phenotype change. Head Neck Pathol. 6:438–444. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Terada T: Adenoid squamous cell carcinoma of the oral cavity. Int J Exp Pathol. 5:442–447. 2012.

17 

Cunha IW, Guimaraes GC, Soares F, Velazquez E, Torres JJ, Chaux A, Ayala G and Cubilla AL: Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: A clinicopathologic and outcome study of 7 patients. Am J Surg Pathol. 33:551–555. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Shah AA, Jeffus SK and Stelow EB: Squamous cell carcinoma variants of the upper aerodigestive tract: A comprehensive review with a focus on genetic alterations. Arch Pathol Lab Med. 138:731–744. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Lee D: Acantholytic squamous cell carcinoma of the esophagus with prevalent single isolated tumour cells including signet ring cells and many osteoclast-like giant cells. Pathology. 48:281–283. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Luna-Moré S, Gonzalez B, Acedo C, Rodrigo I and Luna C: Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Path Res Pract. 190:668–674. 1994. View Article : Google Scholar : PubMed/NCBI

21 

Sánchez-Mora N, Presmanes MC, Monroy V, Moreno N, Lara-Martínez JM, Aladro MH and Álvarez-Fernández E: Micropapillary lung adenocarcinoma: A distinctive histologic subtype with prognostic significance. Case series. Hum Pathol. 39:324–330. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Reis-Filho JS and Ellis IO: Invasive micropapillary carcinoma. In: WHO Classification of Tumours of the Breast4th. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH and van de Vijver MJ: International Agency for Research on Cancer. Lyon: pp. 65–66. 2012

23 

Kozu Y, Isaka M, Ohde Y and Nakajima T: Aggressive adenocarcinoma of the lung consisting solely of discohesive cells. J Cardiothoracic Surg. 8:892013. View Article : Google Scholar

24 

Alwaheeb S and Chetty R: Adenosquamous carcinoma of the pancreas with an acantholytic pattern together with osteoclast-like and pleomorphic giant cells. J Clin Pathol. 58:987–990. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M, et al: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol. 139:17–23. 1991.PubMed/NCBI

26 

Matsukuma S, Aida S, Shima S and Tamai S: Paget's disease of the esophagus. A case report with review of the literature. Am J Surg Pathol. 19:948–955. 1995. View Article : Google Scholar : PubMed/NCBI

27 

Abraham SC, Wang H, Wang KK and Wu TT: Paget cells in the esophagus: Assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma. Am J Surg Pathol. 32:1068–1074. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October-2017
Volume 14 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Matsukuma S, Takahashi O, Utsumi Y, Tsuda M, Miyai K, Okada K and Takeo H: Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma. Oncol Lett 14: 4918-4922, 2017
APA
Matsukuma, S., Takahashi, O., Utsumi, Y., Tsuda, M., Miyai, K., Okada, K., & Takeo, H. (2017). Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma. Oncology Letters, 14, 4918-4922. https://doi.org/10.3892/ol.2017.6804
MLA
Matsukuma, S., Takahashi, O., Utsumi, Y., Tsuda, M., Miyai, K., Okada, K., Takeo, H."Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma". Oncology Letters 14.4 (2017): 4918-4922.
Chicago
Matsukuma, S., Takahashi, O., Utsumi, Y., Tsuda, M., Miyai, K., Okada, K., Takeo, H."Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma". Oncology Letters 14, no. 4 (2017): 4918-4922. https://doi.org/10.3892/ol.2017.6804